Oyster Point Laying Off 50 with Focus on Dry Eye Drug Launch

New Jersey-based Oyster Point Pharma has announced a streamlining plan to reduce operating costs. Although the company promised strong sales-based resources for the launch of dry eye drug Tyrvaya, the streamlining plan will include laying off up to 50 employees.